IT’S hard not to notice the amount of male celebrities who have stepped out sporting a much slimmer frame and chiselled ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

The anti-obesity drug registered sales of ₹100 crore in October, unseating the previous best-selling antibiotic Augmentin, ...

For standard GLP-1 usage, Roslin said that patients are started with a low dose and titrated up to clinical effect. That starting weekly dose is usually 0.25 mg for semaglutide (Ozempic, Wegovy) and 2 ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 drugs, aligning with new drug pricing initiatives and Medicare Part D pilot coverage starting April 2026. Lilly's Zepbound and orforglipron will ...

Novo Nordisk Q3 profit drops on restructuring costs as GLP-1 and obesity drug sales rise; company narrows 2025 growth outlook ...

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, Ozempic, or Wegovy.

US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...

GLP-1 medications are no longer fringe – they’re mainstream, and they’re reshaping everything from public health to consumer behaviour. According to Kim Fisher, director of programs at the Institute ...

GLP-1 medications like Ozempic and Wegovy are reducing users' appetites, leading to changes in dining habits. Some restaurants are beginning to adapt by offering smaller portions and specialized menus ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Orlando restaurant is set to ...